Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Preclinical
Sponsor : GSK
Deal Size : $308.0 million
Deal Type : Collaboration
Relation Forms Collaborations With GSK for Fibrosis And Osteoarthritis Therapeutics
Details : The collaboration aims to focus on the identification and validation of novel therapeutic targets for fibrotic diseases and osteoarthritis.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : $45.0 million
December 10, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Preclinical
Sponsor : GSK
Deal Size : $308.0 million
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Discovery
Sponsor : DCVC
Deal Size : $60.0 million
Deal Type : Financing
Relation Therapeutics Secures $35 Million Seed Financing Led by DCVC and NVentures
Details : The net proceeds will enable Relation to advance its osteoporosis pipeline towards the clinicbe and to accelerate company's discovery of novel biology, targets and medicines.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
March 14, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Discovery
Sponsor : DCVC
Deal Size : $60.0 million
Deal Type : Financing
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $1.3 million
Deal Type : Funding
Relation Therapeutics Teams up With Mila in Coalition to Identify Covid-19 Therapeutic Candidates
Details : Project RE will focus on finding therapies to tackle viral entry and replication and is co-led between Mila (Quebec AI Institute) and Relation Therapeutics.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
September 01, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $1.3 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?